Category Archives: World Pharmaceuticals

NICE Criticism over Guidance for MS Drugs

Multiple-sclerosis experts have urged the National Institute for Health and Care Excellence, (NICE), not to ban two drugs that would alleviate the symptoms of the condition, proving “potentially life-changing.” Steven Bradshaw believes this issue needs to be carefully considered by everyone involved. Continue reading

Rising PBS Costs Eased by Rises in Prescription Drug Prices in Australia

This week the Australian government has announced that in a bid to halt the growth of the Pharmaceutical Benefits Scheme’s (PBS) AU$9 billion-a-year bill, it will act to restrict access to cheap medicines, as well as attach an extra $5 co-payment per prescription. Will this measure prove effective? Continue reading